ANI Pharmaceuticals | ANIP - Assets


ANI Pharmaceuticals reported $1.57B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
ANI Pharmaceuticals USD 1.57B 73.55M Sep/2026
Aurora Cannabis CAD 620.88M 19.79M Jun/2026
Canopy Growth CAD 1.1B 14.81M Jun/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Heron Therapeutics USD 230.45M 21.81M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Novartis USD 117.15B 1.38B Sep/2026
Omeros USD 200.57M 34.59M Jun/2025
Perrigo USD 7.48B 124.6M Sep/2026
Sun Pharmaceuticals INR 1.15T 60.53B Sep/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026